直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Prosecution First Blog

A Tale of Two Methods: Conditions Precedent and Broadest Reasonable Interpretation

November 15, 2016

Authored and Edited by Anthony A. Hartmann; Adriana L. Burgy

PTAB Decision:  Ex parte Schulhauser, Appeal No. 2013-007847 (April 29, 2016)

Background In an appeal of an Examiner’s rejection of claims under 35 U.S.C. § 103, the Board addressed the application of the broadest reasonable interpretation claim construction standard.

The technology related medical devices for monitoring physiological conditions. The independent method claim recited monitoring of cardiac conditions incorporating an implantable medical device applying a series of steps.  It was not disputed that the prior art did not disclose all of these steps.  However, as noted by the Board, “[i]n claim construction, ‘the name of the game is the claim,’” quoting In re Hiniker Co., 150 F.3d 1362, 1369 (Fed. Cir. 1998).  Some of the recited method steps were conditional on a condition precedent, e.g., “triggering an alarm state, if the electrocardiac signal data is not within the threshold electrocardiac criteria.”  Indeed, the steps with conditions meant that the claim, under the broadest reasonable interpretation, “covers at least two methods;”  not just the one promoted by the applicant.  Since one of those methods did not require certain steps to be taken, the Board found that prior art was not required to reach those steps. 

The Board contrasted these method claims to the apparatus claim that recited functions substantially similar to the steps recited in the method claims.  Since the apparatus claim “requires structures for performing the function should the condition occur,” even under the broadest reasonable interpretation, it was necessary for the examiner to identify prior art that rendered the structure obvious.

Issue:  How to interpret a method claim under the broadest reasonable interpretation standard when steps are subject to a condition precedent?

Outcome:  The obviousness rejections of the method claims were affirmed.  The obviousness rejection of the apparatus claim was reversed.

Prosecution Takeaway:  Recognize that when drafting method claims with a conditional limitation, that limitation may not be a limitation for purposes of determining patentability.

Tags

broadest reasonable interpretation (BRI), ex parte reexamination, Obviousness (35 USC § 103), Precedential

Contacts

Anthony A. Hartmann
Of Counsel
Washington, DC
+1 202 408 4275
Email
Adriana L. Burgy
Partner
Washington, DC
+1 202 408 4345
Email

Copyright © 2016 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

Reception

12th Annual Georgia Asian Pacific American Bar Association Gala

May 21, 2026

Atlanta

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP